Envista Holdings Corporation (NVST)

42.88 -0.26 (-0.60%) At close: 04:00PM EST

Envista Holdings Corporation

Building E
200 South Kraemer Boulevard
Brea, CA 92821-6208
United States
714 817 7000
https://www.envistaco.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 12,400

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Amir Aghdaei	Pres, CEO & Director	2.87M	N/A	1959
Mr. Howard H. Yu	Sr. VP & CFO	933.58k	N/A	1973
Mr. Mark E. Nance	Sr. VP, Gen. Counsel & Sec.	828.6k	N/A	1968
Mr. Jean-Claude E. Kyrillos	Sr. VP and Pres of KaVo & DTX	762.77k	N/A	1964
Mr. Patrik Eriksson	Sr. VP & Pres of Nobel Biocare	946.79k	N/A	1968
Kari-Lyn Moore	VP & Chief Accounting Officer	N/A	N/A	N/A
Mr. John C. Moten	VP of Investor Relations	N/A	N/A	N/A
Juan Arbona	Chief Compliance Officer	N/A	N/A	N/A
Mr. Mischa M. Reis	Sr. VP of Strategy & Corp. Devel.	N/A	N/A	1972
Mr. Curt W. Bludworth	Sr. VP & Chief HR Officer	N/A	N/A	1967

Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands. This segment also offers software packages used for the treatment planning of dental implants and prosthetics. The company's Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements, and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, KaVo, Kerr, Metrex, Sybron Endo, Total Care, and Pentron brands to dental offices, clinics, and hospitals. The company was incorporated in 2018 and is headquartered in Brea, California.

Corporate governance

Envista Holdings Corporation’s ISS governance QualityScore as of 26 September 2021 is 2. The pillar scores are Audit: 4; Board: 1; Shareholder rights: 5; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.